NervGen Pharma (NGEN) Stock Price, Quote, News & History | Benzinga

NervGen Pharma Corp (NGEN) Stock Price, Quote, News & History

NGENNASDAQ

Trade with Public

Trade with Public

$2.33

0.010.43%

At close: Sep 2, 5:00 PM EST

$2.30

-0.03-1.29%

After Hours: 6:37 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$2.32

Close

$2.33

Volume / Avg.

383.49K / 705.85K

Day Range

$2.31 - $2.36

52 Wk Range

1.58 - 6.30

Market Cap

$247.30M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

-

Days to Cover

13.83

Recent NervGen Pharma Corp News

Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday

Summary: Wall Street analysts changed rating for JAZZ, AFRM, MNDY, NGEN, FCEL, RRR, ABNB, KARO. See how other analysts view these stocks.

Avi Kapoor

Why Is NervGen Pharma Stock Gaining Tuesday?

NGEN stock climbs as NervGen Pharma NVG-291 hits a 100% responder rate in spinal cord injury gait analysis. Phase 3 set for mid-2026.

Kaustubh Bagalkote

Crude Oil Edges Higher; US Consumer Sentiment Falls In May

US stocks rose, Dow gained over 400 points. S&P 500 and NASDAQ also up. Health care shares jumped, while communication services fell. University of Michigan's consumer sentiment index hit record low. Oil up, gold and silver down. European and Asian markets closed higher.

Avi Kapoor

Dow Jumps 250 Points; BJ's Wholesale Shares Fall After Q1 Results

US stocks rise with the Dow gaining 250 points. Health care shares jump while energy stocks fall. BJ's Wholesale Club stock falls 7% after earnings.

Avi Kapoor

Why Estee Lauder Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Estee Lauder (EL) shares jumped 11.8% in pre-market trading after ending discussions with Puig. Other gainers include PCLA, AKTX, LFS, BIYA, QTEX, GOVX, COHN, SQNS, and IMAX.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-25.65M

Investing Cash Flow (TTM)

58.87K

Financing Cash Flow (TTM)

98.66M

Free Cash Flow (TTM)

-25.65M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

73.07M

Analyst Trends and Forecast

1

Apr

2

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$235.72M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

20.18

Earnings Yield % (TTM)

-24.37%

Earnings Yield % (FWD)

-20.34%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.12

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$58.87K

Total Cash

$86.79M

Debt to Equity

0.00

Issuance of Debt (TTM)

-$58.87K

Repayment of Debt (TTM)

-$58.87K

Key Statistics

Open

$2.32

Close

$2.33

Volume / Avg.

383.49K / 705.85K

Day Range

$2.31 - $2.36

52 Wk Range

1.58 - 6.30

Market Cap

$247.30M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

71

Short Interest

-

Days to Cover

13.83

About

Sector

Health Care

Industry

Pharmaceuticals

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery,...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NervGen Pharma (NGEN) stock?

A

You can purchase shares of NervGen Pharma (NASDAQ:NGEN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NervGen Pharma (NGEN) competitors?

A

Other companies in NervGen Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for NervGen Pharma (NGEN) stock?

A

NervGen Pharma has a consensus price target of $12.50.

Q

What is the current price for NervGen Pharma (NGEN)?

A

The stock price for NervGen Pharma (NASDAQ: NGEN) is $2.3 last updated September 2, 2026 at 6:37 PM EDT.

Q

Does NervGen Pharma (NGEN) pay a dividend?

A

There are no upcoming dividends for NervGen Pharma.

Q

When is NervGen Pharma (NASDAQ:NGEN) reporting earnings?

A

NervGen Pharma does not have any upcoming earnings scheduled.

Q

Is NervGen Pharma (NGEN) going to split?

A

There is no upcoming split for NervGen Pharma.

Q

What sector and industry does NervGen Pharma (NGEN) operate in?

A

NervGen Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.